Our Products
Our CompanyExecutive TeamBoard of DirectorsAdvisory BoardInvestor RelationsOur ScienceFAQsLibraryCareersCLOSE MENU

NEWS

PRESS RELEASE

“Revolutionizing functional foods”: Nurish.Me seeks to boost supplement delivery with nanotech

Nutrition Insight
,
March 1, 2019

Nanotechnology can be used to produce better supplements with increased bioavailability and improved efficacy in delivery and absorption. This is according to Michal Heger, Ph.D., Co-Founder and CFO of Nurish.Me, which has used nanotechnology to create a curcumin supplement coined CoreCumin. Although the use of nanoencapsulation is not widespread yet, Heger notes that a better understanding of this method and appropriate regulatory control could significantly improve supplementation delivery.

READ FULL STORY AT NUTRITION INSIGHTS

INVESTOR RELATIONS:

Stanley Wunderlich

Launchpad IR

+1.800.625.2236
info@cfsg1.com
www.launchpadir.net
MEDIA AND PRESS:

Mike Danielson

President Health & Nutrition Division
Media Relations, Inc

+1.952.697.5214
miked@publicity.com
www.publicity.com

Forward-Looking Statements

This press release may contain forward-looking statements that involve risks and uncertainties. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology including "could," "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential," and the negative of these terms or other comparable terminology. While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions, or other future performance suggested in this report. Except as required by applicable law, we do not intend to update any of the forward-looking statements so as to conform these statements to actual results. Investors should refer to the risks disclosed in the Company's reports filed from time to time with the Securities and Exchange Commission and available at www.sec.gov.